Elevated cathepsin D expression in kainate-evoked rat brain neurodegeneration

Exp Neurol. 1995 Nov;136(1):53-63. doi: 10.1006/exnr.1995.1083.

Abstract

Expression patterns of cathepsin D (lysosomal aspartic protease) and glial fibrillary acidic protein (GFAP, a marker of reactive astroglia) were determined by Northern blot analysis and immunohistochemistry in the rat brain during neurodegeneration accompanying kainate-evoked seizures. The level of cathepsin D mRNA in the hippocampus, limbic cortex, and temporo-parieto-occipital neocortex was shown to increase, starting at 6 h after kainate treatment, and reaching peak values at 3-7 days after the neurotoxin administration. A similar time course of elevated accumulation was noted for GFAP mRNA in these structures. Immunohistochemical analysis performed 3 days after kainate treatment showed that the increased cathepsin D levels were confined mainly to the degenerating neurons in the susceptible brain areas, while the elevated GFAP immunoreactivity was observed in reactive astrocytes. Although cathepsin D and GFAP expression levels were elevated by kainate administration, their expression patterns revealed significant differences with regard to both intensity and site of induction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Northern
  • Brain / metabolism*
  • Cathepsin D / genetics*
  • Cathepsin D / metabolism
  • Cerebral Cortex / immunology
  • Glial Fibrillary Acidic Protein / genetics
  • Immunohistochemistry
  • Kainic Acid / pharmacology
  • Male
  • Nerve Degeneration*
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar
  • Seizures / chemically induced
  • Time Factors

Substances

  • Glial Fibrillary Acidic Protein
  • RNA, Messenger
  • Cathepsin D
  • Kainic Acid